Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 3/20 | 0.41 |
| ▸ | GABRD | O14764 | 3/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.41 |
| ▸ | GABRE | P78334 | 3/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.41 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.41 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.41 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14989249 | 0.90 | GABRP (0.42) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL28477751 | 0.86 | GABRP (0.43) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL7920487 | 0.85 | GABRP (0.40) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4626525 | 0.85 | GABRP (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL3821056 | 0.85 | GABRP (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL21948 | 0.84 | KAT8 (0.46) | PTPN1PPARG | |
| SCHEMBL4639965 | 0.83 | GABRP (0.43) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10456941 | 0.83 | PTPN1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29240829 | 0.83 | GABRP (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL11028104 | 0.83 | GABRP (0.45) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4385503-A2 | ENTERIC COATING FOR SOFT CAPSULE | Capsugel Belgium NV (BE) | 2024-06-19 | — | — | EP | claimed |
| EP-2911654-B1 | ENTERIC COATING FOR SOFT CAPSULE | CAPSUGEL BELGIUM NV (BE) | 2024-06-12 | — | — | EP | claimed |
| CN-116688214-A | Medical gel with stable adhesion in moisture environment and preparation method thereof | 北京福爱乐科技发展有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-20230158004-A1 | ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME | YUNGJIN PHARM. CO., LTD. (KR) | 2023-05-25 | — | — | US | claimed |
| CN-113476421-B | Controlled release composition of febuxostat and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115531493-A | Compound preparation and preparation method thereof | 广西纯正堂制药有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115381787-A | New vitamin C enteric-coated pellet Yinqiao tablet and preparation method thereof | 广西纯正堂制药有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-111405895-B | Controlled release pharmaceutical composition and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-113429662-B | Bright color-changing sunshade net and preparation method thereof | 绿地遮阳有限公司 | 2022-04-22 | — | — | CN | claimed |
| WO-2021215856-A1 | ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME | 영진약품 주식회사 (KR) | 2021-10-28 | — | — | WO | claimed |
| CN-109985016-A | A kind of controlled release composition of Febustat and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-109078186-A | A kind of stomach floating composition and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2018-12-25 | — | — | CN | claimed |
| US-20180056247-A1 | PVDF POWDER FOR LIQUID SLURRIES | ARKEMA INC (US) | 2018-03-01 | — | — | US | claimed |
| EP-3268117-A1 | PVDF POWDER FOR LIQUID SLURRIES | Arkema, Inc. (US) | 2018-01-17 | — | — | EP | claimed |
| CN-107427785-A | PVDF powder for liquid slurry | 阿科玛股份有限公司 | 2017-12-01 | — | — | CN | claimed |
| CN-107224431-A | Improved release dosage form of Febustat and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2017-10-03 | — | — | CN | claimed |
| WO-2016144934-A1 | PVDF POWDER FOR LIQUID SLURRIES | ARKEMA INC. (US) | 2016-09-15 | — | — | WO | claimed |
| CN-105566798-A | Rigid carbon fiber composite material | ANHUI RUIYAN NEW MAT TECH RES INST CO LTD | 2016-05-11 | — | — | CN | claimed |
| US-5658558-A | BLEND OF ACRYLIC HAIR FIXATIVE RESIN AND PLASTICIZER | ROHM AND HAAS COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-0705595-A2 | Hair styling compositions | ROHM AND HAAS COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158004-A1 | ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME | SI, MLN, PIR | GABRP 2991/4885GABRD 4691/4885GABRA1 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.